| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||

Julija Smigelskaite,1,
Christine Doblander,1
Manickam Janakiraman,1,
Martin Hermann,2
Martin Wurm,2
Stefan F. Scheidl,1
Robert Sucher,1
Andrea Deutschmann,2 and
Jakob Troppmair1*
Daniel Swarovski Research Laboratory,1 KMT Laboratory, Department of General and Transplant Surgery, Innsbruck Medical University, 6020 Innsbruck, Austria2
Received 19 April 2007/ Returned for modification 23 July 2007/ Accepted 26 December 2007
Survival signaling by RAF occurs through largely unknown mechanisms. Here we provide evidence for the first time that RAF controls cell survival by maintaining permissive levels of mitochondrial reactive oxygen species (ROS) and Ca2+. Interleukin-3 (IL-3) withdrawal from 32D cells resulted in ROS production, which was suppressed by activated C-RAF. Oncogenic C-RAF decreased the percentage of apoptotic cells following treatment with staurosporine or the oxidative stress-inducing agent tert-butyl hydroperoxide. However, it was also the case that in parental 32D cells growing in the presence of IL-3, inhibition of RAF signaling resulted in elevated mitochondrial ROS and Ca2+ levels. Cell death is preceded by a ROS-dependent increase in mitochondrial Ca2+, which was absent from cells expressing transforming C-RAF. Prevention of mitochondrial Ca2+ overload after IL-3 deprivation increased cell viability. MEK was essential for the mitochondrial effects of RAF. In summary, our data show that survival control by C-RAF involves controlling ROS production, which otherwise perturbs mitochondrial Ca2+ homeostasis.
Published ahead of print on 22 January 2008.
These authors contributed equally to this work.
Present address: Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|